Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.100
0.00 (0.00%)
At close: May 28, 2025, 4:00 PM
1.180
+0.080 (7.27%)
Pre-market: May 29, 2025, 5:12 AM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $34.49 million as of May 28, 2025. Its market cap has decreased by -86.28% in one year.
Market Cap
34.49M
Enterprise Value
-111.63M
1-Year Change
-86.28%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $34.49M, a decrease of -85.33%. That is a compound annual growth rate of -53.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2025 | 34.49M | -81.60% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.82B |
| Johnson & Johnson | 366.76B |
| AbbVie | 323.41B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.43B |
| Abbott Laboratories | 229.69B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |